SFLT-1 selective apheresis device

selective removal of soluble fms-like tyrosine kinase-1 (sFlt-1) via apheresis · Miltenyi Biomedicine GmbH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SFLT-1 selective apheresis device, covering 2025-09-30 to 2025-09-30. Get the full timeline:

Most recent: Clinical Trial Update: Proof-of-Concept Trial on Selective Removal of sFlt-1 in Pregnant Women With Preeclampsia Via Apheresis [NA]